Correlation Between Apple and SCHOTT Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apple and SCHOTT Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apple and SCHOTT Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apple Inc and SCHOTT Pharma AG, you can compare the effects of market volatilities on Apple and SCHOTT Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of SCHOTT Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and SCHOTT Pharma.

Diversification Opportunities for Apple and SCHOTT Pharma

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Apple and SCHOTT is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and SCHOTT Pharma AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCHOTT Pharma AG and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with SCHOTT Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCHOTT Pharma AG has no effect on the direction of Apple i.e., Apple and SCHOTT Pharma go up and down completely randomly.

Pair Corralation between Apple and SCHOTT Pharma

Assuming the 90 days trading horizon Apple Inc is expected to generate 0.65 times more return on investment than SCHOTT Pharma. However, Apple Inc is 1.54 times less risky than SCHOTT Pharma. It trades about 0.41 of its potential returns per unit of risk. SCHOTT Pharma AG is currently generating about -0.21 per unit of risk. If you would invest  20,560  in Apple Inc on September 2, 2024 and sell it today you would earn a total of  1,890  from holding Apple Inc or generate 9.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Apple Inc  vs.  SCHOTT Pharma AG

 Performance 
       Timeline  
Apple Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Apple Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady fundamental indicators, Apple may actually be approaching a critical reversion point that can send shares even higher in January 2025.
SCHOTT Pharma AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCHOTT Pharma AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Apple and SCHOTT Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apple and SCHOTT Pharma

The main advantage of trading using opposite Apple and SCHOTT Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, SCHOTT Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCHOTT Pharma will offset losses from the drop in SCHOTT Pharma's long position.
The idea behind Apple Inc and SCHOTT Pharma AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets